Clinical Features and Outcomes of Patients with Hodgkin's Lymphoma: A Study from a Tertiary Cancer Centre
International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064


Downloads: 6 | Views: 170 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1

Analysis Study Research Paper | Oncology Science | India | Volume 14 Issue 2, February 2025 | Popularity: 5.4 / 10


     

Clinical Features and Outcomes of Patients with Hodgkin's Lymphoma: A Study from a Tertiary Cancer Centre

Dr. Abhilash B, Dr. K Chandralekha, Dr. PN Sathiyamoorthy


Abstract: Background and Aim: Hodgkin's lymphoma, a cancer of the lymphatic system, predominantly affects individuals aged 20-40 years. While curable, treatment responses remain unpredictable. This study aimed to analyze the clinical profile, prognostic factors, and treatment outcomes of Hodgkin's lymphoma patients in a tertiary care hospital. Methods: A retrospective review of hospital records (2017-2018) was conducted on 38 Hodgkin's lymphoma patients, examining demographics, clinical presentations, histological subtypes, staging, prognostic scores, PET CT imaging, treatment regimens, response rates, toxicity, and outcomes. Results: The cohort showed a male predominance, with a median age of 28 years. B symptoms were the most common presentation (28%), and lymphadenopathy was present in 42% of early - stage and 58% of advanced - stage patients. Extranodal disease occurred in 38%, marrow involvement in 5%, and bulky disease in 19%. Nodular sclerosis was the most common histological subtype. PET CT revealed a 65% complete response rate. Low - risk patients (IPS) comprised 85% of the cohort. The ABVD regimen was the most frequently used; 34% of patients received radiotherapy post - chemotherapy. Stage I/II patients achieved >80% remission, while remission dropped to 66% in stages III/IV. Myelosuppression and lung toxicity occurred in 15% and 10%, respectively, with one treatment - related mortality due to bleomycin lung toxicity. Conclusion: The study highlights male predominance and younger onset compared to Western populations. Complete remission was high in early - stage patients, declining in advanced stages, consistent with global data. Higher nodular sclerosis incidence and early - stage presentation contrasted with Indian data.


Keywords: Hodgkin's lymphoma, clinical profile, treatment outcomes, prognostic factors, remission rates


Edition: Volume 14 Issue 2, February 2025


Pages: 763 - 765


DOI: https://www.doi.org/10.21275/SR25211123159


Please Disable the Pop-Up Blocker of Web Browser

Verification Code will appear in 2 Seconds ... Wait



Text copied to Clipboard!
Dr. Abhilash B, Dr. K Chandralekha, Dr. PN Sathiyamoorthy, "Clinical Features and Outcomes of Patients with Hodgkin's Lymphoma: A Study from a Tertiary Cancer Centre", International Journal of Science and Research (IJSR), Volume 14 Issue 2, February 2025, pp. 763-765, https://www.ijsr.net/getabstract.php?paperid=SR25211123159, DOI: https://www.doi.org/10.21275/SR25211123159

Top